psalexa
logo

Clinical Decision Support System Market

Global Clinical Decision Support System (CDSS) Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Product (Integrated and Standalone), by Application (Drug Dosing Support, Clinical Guidelines, Clinical Reminders, Drug-Drug Interactions, Drug Allergy Alerts, and Others), By Model (Knowledge-Based, and Non-Knowledge-Based), By Mode of Delivery (Web-Based, Cloud-Based and On-Premises), By Component (Software, Hardware, and Services), and By Healthcare Provider Entity Capacity

Published: August 2016
Report Code: LS10611
Available Format:
Pages: 185
Category : Healthcare IT

The global CDSS market was valued at $410.5 million in 2015, and it is expected to grow at a CAGR of 21.5% during 2016-2022. Among the various products, the integrated CDSS segment is expected to witness the fastest growth during the forecast period, at a CAGR of 22.4%. The global CDSS market is growing at a significant rate, due to growing demand for advanced healthcare information systems, and growing investments by HIT players.

CDSSs are computer-based information systems that are designed to assist healthcare providers in the implementation of clinical guidelines at the point of care. The systems use patient information to provide evidence-based treatment recommendation for healthcare providers and delivers better clinical outcomes. CDSS are often incorporated within electronic health records (EHR) and integrated with other computer-based functions that provide patient-care summary reports, and feedback on quality indicators.

Clinical Decision Support System Market

Moreover, the growing need for remote patient monitoring services, increasing demand of mHealth technologies, and increasing support from government organizations are also driving the growth of the global CDSS market.

The growing geriatric population, increasing prevalence of chronic diseases and lack of primary healthcare facilities in remote areas of developing nations are increasing the demand of remote patient monitoring services, which further require telemedicine and CDSS services for the streamlining of clinical procedures.

As per the United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of people aged 60 years or above is growing with high rate. The number has increased from a global share of 9.2% in 1990 to 11.7% in 2013, and is expected to reach 21.1% by the end of 2050.

The restraints associated with the growth of the global CDSS market include privacy and security issues; high capital expenditure and maintenance requirement; and inadequate healthcare infrastructure in developing economies. Literacy and security issues, high capital expenditure and maintenance requirement, and inadequate healthcare infrastructure in developing economies are inhibiting the growth of the global market. The increasing popularity of CDSS in healthcare facilities is the key trend observed in the global CDSS market.

Geographically, North America is expected to maintain dominance in the global market of CDSS during 2016-2022. This is due to improved healthcare infrastructure, increased healthcare spends, growing geriatric population, and growing prevalence of chronic and lifestyle associated diseases. In addition, the increased awareness about innovative and advanced applications of CDSS is also supporting the growth of the CDSS Market in North America.

The European CDSS market is growing, mainly due to growing aging population, and increasing prevalence of chronic diseases. However, the Asia-Pacific market of CDSS is expected to witness the highest growth globally, during the forecast period. This is due to growing geriatric population and upsurge in the occurrence rate of different chronic diseases. Additionally, the increased patient demand and increasing life expectancy are likely to increase IT investments in healthcare industry in the region.

Some of the key companies operating in the global CDSS market include Cerner Corporation, RELX Group PLC, Epic Systems Corporation, General Electric Company, McKesson Corporation, Zynx Health Incorporated, International Business Machine Corporation, Siemens AG, Allscripts Healthcare Solutions Inc., Meditech and Wolters Kluwer.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5500
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry